LSPedia Awarded MMCAP Infuse National Contract for FDA DSCSA Compliance

LSPedia’s OneScan Suite Transforms Healthcare Operations with Seamless FDA DSCSA Compliance, Integration, and Unmatched Supply Chain Insights.

FARMINGTON HILLS, Mich., Feb. 26, 2025 /PRNewswire/ — LSPedia, a global leader in pharmaceutical traceability and supply chain SaaS solutions, has secured its second major U.S. government contract, the MMCAP Infuse DSCSA Compliance contract. This follows its national DSCSA contract with the U.S. Department of Veterans Affairs, further solidifying LSPedia’s leadership position in the US pharmaceutical supply chain.

MMCAP Infuse is a healthcare group purchasing organization that provides contracts for medical supplies, pharmaceuticals, services and compliance solutions.  Through this contract, MMCAP Infuse’s 17,000+ member facilities—including hospitals, correctional facilities, and public health clinics—gain access to LSPedia’s best in class traceability solution to ensure seamless FDA DSCSA compliance, enhance patient safety, and automate pharmacy workflows. In addition, LSPedia’s unmatched EHR, WMS, and PMS integrations eliminate redundant scanning and manual data entry, saving each facility hours of manual process receiving and reconciliation, freeing pharmacists and technicians to focus on patient care and revenue-fgenerating activities.

MMCAP Infuse member facilities will also be able to implement LSPedia’s advanced Recall Management and Expiration Management systems relevant to in-stock inventory. This intelligent recall management system eliminates noise from irrelevant notifications, brings focus to staff, and ensures full compliance with regulatory requirements.

Additionally, LSPedia’s Investigator™ is the industry’s only fully automated, collaborative Exceptions Management platform, resolving EPCIS, VRS, and logistics exceptions in near real-time across the pharmaceutical supply chain. By eliminating manual exception handling, Investigator streamlines compliance, prevents supply chain disruptions, and ensures data accuracy between trading partners.

“Hospitals and healthcare facilities need more than just DSCSA compliance; they need a solution that enhances efficiency and strengthens their bottom line,” said Daniel MacKinnon, SVP of Sales and Marketing at LSPedia. “With this contract, MMCAP Infuse members gain access to the best-in-class tools to streamline operations, reduce administrative burdens, and focus on what matters most—delivering exceptional patient care.”

For more information about LSPedia’s solutions for MMCAP Infuse members, visit www.lspedia.com or contact TRACE@lspedia.com.

About MMCAP Infuse

MMCAP Infuse is a national cooperative group purchasing organization that provides pharmaceuticals, medical supplies, and healthcare solutions at reduced costs to government facilities. With over 17,000 member sites, MMCAP Infuse helps government healthcare providers secure essential medical products while ensuring full regulatory compliance.

About LSPedia

LSPedia is a global leader in traceability and supply chain SaaS solutions, delivering seamless, end-to-end pharmaceutical compliance and cradle-to-grave market visibility. Its OneScan™ suite ensures global traceability and serialization compliance, enhances supply chain transparency, and protects patient safety by preventing counterfeit and unlicensed products from reaching consumers. Headquartered in Farmington Hills, Mich., with offices in the U.S., India, Singapore, and Bulgaria, LSPedia supports a worldwide network of pharmaceutical partners.

Media Contact:
Eric Kushner
248-987-5856
390759@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lspedia-awarded-mmcap-infuse-national-contract-for-fda-dscsa-compliance-302385682.html

SOURCE LSPedia